163 related articles for article (PubMed ID: 8676522)
1. Sequence determinants of 3A-mediated resistance to enviroxime in rhinoviruses and enteroviruses.
Heinz BA; Vance LM
J Virol; 1996 Jul; 70(7):4854-7. PubMed ID: 8676522
[TBL] [Abstract][Full Text] [Related]
2. The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus.
Heinz BA; Vance LM
J Virol; 1995 Jul; 69(7):4189-97. PubMed ID: 7769678
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307.
De Palma AM; Thibaut HJ; van der Linden L; Lanke K; Heggermont W; Ireland S; Andrews R; Arimilli M; Al-Tel TH; De Clercq E; van Kuppeveld F; Neyts J
Antimicrob Agents Chemother; 2009 May; 53(5):1850-7. PubMed ID: 19237651
[TBL] [Abstract][Full Text] [Related]
4. Evidence that enviroxime targets multiple components of the rhinovirus 14 replication complex.
Brown-Augsburger P; Vance LM; Malcolm SK; Hsiung H; Smith DP; Heinz BA
Arch Virol; 1999; 144(8):1569-85. PubMed ID: 10486111
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiviral activity of C2 analogs of enviroxime: an exploration of the role of critical functionality.
Victor F; Loncharich R; Tang J; Spitzer WA
J Med Chem; 1997 Oct; 40(21):3478-83. PubMed ID: 9341923
[TBL] [Abstract][Full Text] [Related]
6. Antiviral therapy for enteroviruses and rhinoviruses.
Rotbart HA
Antivir Chem Chemother; 2000 Jul; 11(4):261-71. PubMed ID: 10950388
[TBL] [Abstract][Full Text] [Related]
7. Antiviral agents against picornaviruses.
Eggers HJ
Antiviral Res; 1985; Suppl 1():57-65. PubMed ID: 3002267
[No Abstract] [Full Text] [Related]
8. [In vitro effectiveness of new antiviral substances. 2. studies with enteroviruses and rhinovirus lB].
Tonew M; Tonew E; Oehring H; Schmidt J
Virologie; 1985; 36(2):111-7. PubMed ID: 2994289
[TBL] [Abstract][Full Text] [Related]
9. Screening of a Library of FDA-Approved Drugs Identifies Several Enterovirus Replication Inhibitors That Target Viral Protein 2C.
Ulferts R; de Boer SM; van der Linden L; Bauer L; Lyoo HR; Maté MJ; Lichière J; Canard B; Lelieveld D; Omta W; Egan D; Coutard B; van Kuppeveld FJ
Antimicrob Agents Chemother; 2016 May; 60(5):2627-38. PubMed ID: 26856848
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity.
Arita M; Kojima H; Nagano T; Okabe T; Wakita T; Shimizu H
J Virol; 2011 Mar; 85(5):2364-72. PubMed ID: 21177810
[TBL] [Abstract][Full Text] [Related]
11. Antiviral properties of 1-allyl and 1-crotyl derivatives of 2-( -hydroxybenzyl) benzimidazole.
O'Sullivan DG; Ludlow CM
Experientia; 1972 Aug; 28(8):889-90. PubMed ID: 4342512
[No Abstract] [Full Text] [Related]
12. Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds.
Smee DF; Evans WJ; Nicolaou KC; Tarbet EB; Day CW
Antiviral Res; 2016 Jul; 131():61-5. PubMed ID: 27063860
[TBL] [Abstract][Full Text] [Related]
13. A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus.
Stone JK; Rijnbrand R; Stein DA; Ma Y; Yang Y; Iversen PL; Andino R
Antimicrob Agents Chemother; 2008 Jun; 52(6):1970-81. PubMed ID: 18347107
[TBL] [Abstract][Full Text] [Related]
14. Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes.
Wyde PR; Six HR; Wilson SZ; Gilbert BE; Knight V
Antimicrob Agents Chemother; 1988 Jun; 32(6):890-5. PubMed ID: 2843086
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity in tissue culture systems of bis-benzimidazoles, potent inhibitors of rhinoviruses.
Schleicher JB; Aquino F; Rueter A; Roderick WR; Appell RN
Appl Microbiol; 1972 Jan; 23(1):113-6. PubMed ID: 4333892
[TBL] [Abstract][Full Text] [Related]
16. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.
Ledford RM; Patel NR; Demenczuk TM; Watanyar A; Herbertz T; Collett MS; Pevear DC
J Virol; 2004 Apr; 78(7):3663-74. PubMed ID: 15016887
[TBL] [Abstract][Full Text] [Related]
17. Coxsackievirus mutants that can bypass host factor PI4KIIIβ and the need for high levels of PI4P lipids for replication.
van der Schaar HM; van der Linden L; Lanke KH; Strating JR; Pürstinger G; de Vries E; de Haan CA; Neyts J; van Kuppeveld FJ
Cell Res; 2012 Nov; 22(11):1576-92. PubMed ID: 22945356
[TBL] [Abstract][Full Text] [Related]
18. Antirhino/enteroviral vinylacetylene benzimidazoles: a study of their activity and oral plasma levels in mice.
Tebbe MJ; Spitzer WA; Victor F; Miller SC; Lee CC; Sattelberg TR; McKinney E; Tang JC
J Med Chem; 1997 Nov; 40(24):3937-46. PubMed ID: 9397174
[TBL] [Abstract][Full Text] [Related]
19. The nucleotide sequence of human rhinovirus 1B: molecular relationships within the rhinovirus genus.
Hughes PJ; North C; Jellis CH; Minor PD; Stanway G
J Gen Virol; 1988 Jan; 69 ( Pt 1)():49-58. PubMed ID: 2826669
[TBL] [Abstract][Full Text] [Related]
20. Selective human enterovirus and rhinovirus inhibitors: An overview of capsid-binding and protease-inhibiting molecules.
Shih SR; Chen SJ; Hakimelahi GH; Liu HJ; Tseng CT; Shia KS
Med Res Rev; 2004 Jul; 24(4):449-74. PubMed ID: 15170592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
